Delivery Order SPE2DB22D3016-SPE2DB25FATA7

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,721.53, is for the supply of NALTREXONE 50 MG TABLET 90S, a medication used in the treatment of opioid use disorder. The contract is a firm fixed-price delivery order with an ultimate completion date of October 31, 2023. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.32 firm-fixed-price delivery order is for the supply of NALTREXONE 50 MG TABLET 30S, a medication used in the treatment of opioid and alcohol dependence. The contract has a completion date of July 31, 2023 and was awarded on July 28, 2023. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,299.82, is for the delivery of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $14,187.84 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract has a firm fixed price and an ultimate completion date of February 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $38,144.01 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract is for the supply of NALTREXONE 50 MG TABLET 60S, a medication used in the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,482.80, is for the delivery of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract has a completion date of February 24, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, with the ID SPE2DB22D3016|SPE2DB25FADE5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of NALTREXONE 50 MG TABLET 60S, a medication used for the treatment of opioid dependence. The contract has a ceiling value of $3,530.16 and a completion date of November 14, 2024....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,862.52 Firm Fixed Price Delivery Order contract is for the supply of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid dependence. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Naltrexone 50 mg tablets, a medication used to treat opioid addiction. The contract is a firm-fixed price delivery order with a ceiling value of $7,192.66 and a period of performance ending on May 2, 2025. This order is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count tablets of the drug Naltrexone 50 mg, a medication used to treat opioid and alcohol dependence. The contract has a ceiling value of $12,670.26 and an ultimate completion date of October 24, 2024. This delivery order is a part of a larger Indefinite Delivery...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FATA7
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,948.05 and is for the delivery of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/3/25, 3:00 PM